The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...
The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.
Key PointsChikungunya virus (CHIKV) is a mosquito-borne RNA virus first identified in Tanzania in the 1950s.Chikungunya is generally characterized by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback